| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.5M | +26.9% |
| Cost of Revenue | $27.6M | +31.3% |
| R&D Expense | $5.3M | -13.2% |
| SG&A Expense | $26.5M | +1.5% |
| Operating Income | -$10.7M | +12.8% |
| Pre-tax Income | -$31.4M | -118.3% |
| Net Income | -$31.4M | -118.3% |
| EPS (Basic) | -$2.73 | -108.4% |
| EPS (Diluted) | -$2.73 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.3M | -21.1% |
| Short-term Investments | $6.2M | +79.8% |
| Accounts Receivable | $6.1M | +52.1% |
| Inventory | $11.4M | -27.2% |
| Current Assets | $42.0M | -9.6% |
| Total Assets | $66.3M | -4.7% |
| Current Liabilities | $15.0M | +29.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.3M | +76.4% |
| Capital Expenditures | $156K | -33.9% |
| Investing Cash Flow | -$2.2M | +48.0% |
| Financing Cash Flow | $78K | -99.6% |
| Free Cash Flow | -$2.4M | +75.4% |
| -108.4% |
| Total Liabilities |
| $47.7M |
| +112.6% |
| Stockholders' Equity | $4.9M | -85.5% |